Results 121 to 130 of about 4,276 (147)

[Clinical characteristics and survival outcomes of patients with immunoglobulin A multiple myeloma in the bortezomib era: A single-center retrospective cohort study]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Gao F, Wang H, Zhou YL, Wang SX, Yu M, Li F.   +5 more
europepmc   +1 more source

[Expression of GPRC5D in newly diagnosed patients with multiple myeloma detected by flow cytometry and its prognostic value]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Jin CQ, Yan F, Ma A, Xu KL, Xia JY.
europepmc   +1 more source

[Renal response and prognosis of newly diagnosed patients with multiple myeloma with renal impairment applying VRD and autologous hematopoietic stem cell transplantation]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Wu XY, Huang Y, Shen HM, You HY, Yan Z, Xie Y, Yao WQ, Yan S, Wang J, Zhai YY, Shi XL, Shang JJ, Jin S, Yan LZ, Wu DP, Fu CC.   +15 more
europepmc   +1 more source

[Chinese guidelines on response assessment and minimal residual disease monitoring in multiple myeloma (2024)]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Multiple Myeloma Expert Committee of Chinese Society of Clinical Oncology (CSCO), Myeloma & Plasma Cell Disease Group, Hematology Oncology Committee of China Anti-Cancer Association (CACA).   +2 more
europepmc   +1 more source

[Prognostic analysis of 19 newly treated multiple myeloma patients with t(14; 16)]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Li Y, Liu JR, Li J, Chen WM.
europepmc   +1 more source

原发性肋骨恶性淋巴瘤一例 [PDF]

, 2003
叶锋, 康江河, 李怀波, 王金岸
core  

2020 年上海市恶性肿瘤发病率 [PDF]

core   +1 more source

[Effects and mechanisms of the kidney-reinforcing and blood circulation-activating and collateral dredging decoction metabolites on the proliferation of multiple myeloma KM3 cells]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Shi JB, Li CN, Wei WJ, Ding JY, Ma GD, Li LL, Wang YR, Lu YT, Xu J, Zheng W, Wang Y, Wang JY, Xu RR, Cui SY.   +13 more
europepmc   +1 more source

[The Chinese clinical expert consensus for the BCMA bispecific T cell engager in the treatment of multiple myeloma (2025)]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Chinese Hematology Association, Chinese Myeloma Committee, Plasma Cell Disease Group, Chinese Society of Hematology, Chinese Medical Association, Chinese Geriatrics Association, Society of Hematology.   +6 more
europepmc   +1 more source

[Expert consensus on the comprehensive management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma in China (2025)]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Plasma Cell Disease Group, Chinese Society of Hematology, Chinese Medical Association, Chinese Myeloma Committee-Chinese Hematology Association.   +3 more
europepmc   +1 more source